These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16634706)

  • 1. Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy.
    Epstein JB; Klasser GD
    Expert Opin Emerg Drugs; 2006 May; 11(2):353-73. PubMed ID: 16634706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management.
    Epstein JB; Schubert MM
    Oncology (Williston Park); 2003 Dec; 17(12):1767-79; discussion 1779-82, 1791-2. PubMed ID: 14723014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2004 Jan; 26(1):77-84. PubMed ID: 14724910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies for management of oral mucositis in cancer patients.
    Peterson DE
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia.
    Radvansky LJ; Pace MB; Siddiqui A
    Am J Health Syst Pharm; 2013 Jun; 70(12):1025-32. PubMed ID: 23719879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucositis in myelosuppressive cancer therapy.
    Epstein JB; Schubert MM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Sep; 88(3):273-6. PubMed ID: 10503852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM; Lenz KL
    Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of oral mucositis.
    Silverman S
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):13-21. PubMed ID: 17366929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for chemotherapy-induced mucositis.
    Keefe DM; Sonis ST; Bowen JM
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):511-22. PubMed ID: 18764726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy.
    Peterson DE; Cariello A
    Semin Oncol; 2004 Jun; 31(3 Suppl 8):35-44. PubMed ID: 15181607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
    Beaven AW; Shea TC
    Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Evaluation of Palifermin Use in Nonhematopoietic Stem Cell Transplant Pediatric Patients.
    Liu D; Seyboth B; Mathew S; Gilheeney SW; Chou AJ; Drill E; Kobos R
    J Pediatr Hematol Oncol; 2017 May; 39(4):e177-e182. PubMed ID: 28234746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucositis: pathobiology and management.
    Villa A; Sonis ST
    Curr Opin Oncol; 2015 May; 27(3):159-64. PubMed ID: 25774860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.
    Saadeh CE
    Pharmacotherapy; 2005 Apr; 25(4):540-54. PubMed ID: 15977916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F; Bez C; Carrassi A
    Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mucositis due to cancer treatments. Orodental hygiene and ice cubes.
    Prescrire Int; 2008 Feb; 17(93):33-5. PubMed ID: 18383657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.
    Vadhan-Raj S; Goldberg JD; Perales MA; Berger DP; van den Brink MR
    J Cell Mol Med; 2013 Nov; 17(11):1371-84. PubMed ID: 24251854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.
    Blijlevens N; Sonis S
    Ann Oncol; 2007 May; 18(5):817-26. PubMed ID: 17030544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.